Home  |  Site Map  | Contact
Text size: AA   AA   AA


Alexander Lussow, Senior Vice President, Business Development and Commercial Operations
Alexander Lussow joined QLT in July 2006 as Vice President, Business Development and became Senior Vice President, Business Development and Commercial Operations in May 2008.

Dr. Lussow is responsible for QLT's business development activities, including product licensing, acquisitions and strategic partnering opportunities, as well as QLT's product manufacturing and supply chain.

Before joining QLT, Dr. Lussow was Gryphon Therapeutics' Chief Business Officer and Vice President of Business Development where he was responsible for the licensing of the company's products, the formation of strategic alliances, corporate communications and fund raising. Before joining Gryphon, Dr. Lussow served as the head of business development at Sangstat Medical Corporation (now wholly- owned by Genzyme Corp.). He also has broad experience in biotechnology management consulting, advising on venture financing, strategic business planning and licensing transactions for several biotechnology companies.

Dr. Lussow received his Bachelor of Science degree at McGill University in Montreal and his PhD in immunology at the University of Geneva, Switzerland. He has been an adjunct professor of pharmacology at the University of North Carolina, USA and has worked extensively for the World Health Organization (WHO) in West Africa.

Copyright © 2000-2015 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking